C-MER Eye Care Holdings Limited

符号: 3309.HK

HKSE

3.11

HKD

今天的市场价格

62.7191
市盈率
0.0000
PEG比率
3.87B
MRK市值
0.00%
DIV收益率

C-MER Eye Care Holdings Limited (3309-HK) 财务报表

Q: 什么是 C-MER Eye Care Holdings Limited (3309.HK) 总资产是多少？

C-MER Eye Care Holdings Limited (3309.HK) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 C-MER Eye Care Holdings Limited (3309.HK). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 C-MER Eye Care Holdings Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014
balance-sheet.row.cash-and-short-term-investments	557.4	698.5	442.4	553.9	535.9	732.2	78	71	46.9	29.2
balance-sheet.row.short-term-investments	44.7	53.8	55.7	0	253.7	249.1	0.1	12.2	23.5	18
balance-sheet.row.net-receivables	66.7	53.9	30.1	15	13.4	6.3	7.7	6.5	39.9	1.7
balance-sheet.row.inventory	42	55.6	34.5	25.1	17.9	9.2	7.6	2.3	1.5	2
balance-sheet.row.other-current-assets	54.1	48.6	239.5	17.2	14.6	26.3	16.7	12.6	42.2	21.7
balance-sheet.row.total-current-assets	720.1	856.6	746.4	611.2	581.7	762.6	110	85.9	90.6	52.9
balance-sheet.row.property-plant-equipment-net	1000.3	1057.6	901.3	794.5	370.1	110.5	109.2	29.6	30.3	40.4
balance-sheet.row.goodwill	530.4	540.7	195	138.5	99.5	0	0	0	0	0
balance-sheet.row.intangible-assets	558.2	821.4	204	144.9	104.6	3.8	2.5	1.4	1.6	1.4
balance-sheet.row.goodwill-and-intangible-assets	1088.6	1362.1	398.9	283.5	204.1	3.8	2.5	1.4	1.6	1.4
balance-sheet.row.long-term-investments	193.1	129.2	77.4	54.5	2.2	113.3	110.7	-7	-18.3	-12.7
balance-sheet.row.tax-assets	6.8	6.9	11	3.1	5	1	0.9	0.7	0	0
balance-sheet.row.other-non-current-assets	-260.3	-510.7	-179.1	-117.6	-43.5	-114.3	-0.9	18.1	28.2	20.9
balance-sheet.row.total-non-current-assets	2028.5	2045.1	1209.5	1018	537.9	114.3	111.6	42.8	41.8	49.9
balance-sheet.row.other-assets	0	0	0	0	0	10	11.7	0	0	0
balance-sheet.row.total-assets	2748.6	2901.7	1955.9	1629.2	1119.6	886.8	233.4	128.6	132.4	102.8
balance-sheet.row.account-payables	54.9	45.3	39.9	19	13.8	5.4	6.9	3.1	2.3	2.5
balance-sheet.row.short-term-debt	116.5	149.3	265.5	67.6	43.2	0.7	8.3	17.5	26.9	37.2
balance-sheet.row.tax-payables	24	18.9	8.5	5.4	12.3	3.6	6.2	5.2	7.8	5.8
balance-sheet.row.long-term-debt-total	13.8	21.2	7.6	177.4	128.4	1.7	0.7	1	6.4	6.7
Deferred Revenue Non Current	232.7	281.9	198.6	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	163.7	290.7	92.2	57.1	64.9	41.5	57.2	42.2	28.2	25
balance-sheet.row.total-non-current-liabilities	366	378.6	210.4	179.7	128.4	1.7	0.7	1.2	7	7.3
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	232.7	281.9	198.6	177.4	128.4	1.7	0.7	7.4	12.7	10
balance-sheet.row.total-liab	755.3	903.4	618.6	332	258.3	53.1	76	65.2	65.4	72
balance-sheet.row.preferred-stock	1520.5	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	125.6	126.7	115	114.7	105.1	103.5	0	0	0	0
balance-sheet.row.retained-earnings	77.4	26.6	50.5	52.9	81.6	72	29.4	66.5	67.4	29.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	-3.1	9.6	79	55	16.6	13.3	11.4	-40.9	-29.9	-19.2
balance-sheet.row.other-total-stockholders-equity	125.6	1703.2	1086.7	1071.7	653.4	644.9	116.5	37.8	29.4	20.1
balance-sheet.row.total-stockholders-equity	1845.8	1866.1	1331.2	1294.3	856.7	833.7	157.4	63.4	66.9	30.8
balance-sheet.row.total-liabilities-and-stockholders-equity	2748.6	2901.7	1955.9	1629.2	1119.6	886.8	233.4	128.6	132.4	102.8
balance-sheet.row.minority-interest	147.5	132.2	6	2.9	4.6	0	0	0	0	0
balance-sheet.row.total-equity	1993.3	1998.2	1337.2	1297.2	861.3	833.7	157.4	63.4	66.9	30.8
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-
Total Investments	237.7	183	133.1	54.5	255.9	249.1	0.1	5.2	5.2	5.2
balance-sheet.row.total-debt	363	452.5	471.7	245	171.7	2.5	8.9	18.5	33.3	43.9
balance-sheet.row.net-debt	-149.8	-192.2	85	-309	-110.5	-469.3	-69	-40.2	10	32.6

现金流量表

在 C-MER Eye Care Holdings Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014
cash-flows.row.net-income	62	-21.9	21.9	-6.2	41.4	42.6	40.1	58.6	48.4	28
cash-flows.row.depreciation-and-amortization	0	223.7	148.6	113.6	78.5	25.5	8.6	12.4	11.6	11
cash-flows.row.deferred-income-tax	0	-483.2	-309.4	-236.6	-164.8	-5.4	1.3	0	0	0
cash-flows.row.stock-based-compensation	0.1	1.3	4.3	5	4.9	6.5	6.3	0	0	0
cash-flows.row.change-in-working-capital	0	-32.7	-7.4	-1.5	14.5	-1.2	-7.5	-2.4	-0.5	4.1
cash-flows.row.account-receivables	0	-26.7	-18.5	-3.1	-4.4	1.3	-3.1	-1.1	-1.8	-0.8
cash-flows.row.inventory	0	-8.7	-9.2	-5.6	-3.7	-2.5	-4.4	-0.9	0.5	0.3
cash-flows.row.account-payables	0	0.9	19.7	4.3	5.2	-1.4	3.7	0.7	-0.2	0.8
cash-flows.row.other-working-capital	0	1.7	0.6	3	17.4	1.4	-3.7	-1.1	1	4.6
cash-flows.row.other-non-cash-items	-62.1	504.6	290.6	229.8	166	-27.2	18.1	-15.1	-9	-0.4
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	-91.2	-129.2	-337.4	-171.9	-31.7	-65.6	-11.3	-3.1	-8
cash-flows.row.acquisitions-net	0	-80.3	-223.5	-39.3	-96.3	0.2	0.1	-11.9	-15.6	-4.8
cash-flows.row.purchases-of-investments	0	-39.2	-40	-34.9	-7	-16.5	-27.7	-78.7	-92.3	-71.9
cash-flows.row.sales-maturities-of-investments	0	106.7	277.6	253.7	11.2	4.8	40.6	89.7	85.9	56
cash-flows.row.other-investing-activites	0	-106.7	-277.6	0	0	-231.4	-37.3	-1.7	-0.6	0.3
cash-flows.row.net-cash-used-for-investing-activites	0	-210.7	-392.7	-157.9	-264	-274.6	-89.9	-13.8	-25.7	-28.4
cash-flows.row.debt-repayment	0	-162	-174.4	-55.5	-46.4	-8.7	-27.6	-15.8	-36.3	-41.7
cash-flows.row.common-stock-issued	0	607.7	9.2	399.4	1.6	657.6	142	0	0	0
cash-flows.row.common-stock-repurchased	0	-29.9	-88.6	-333.5	45.6	0	-114.4	0	0	0
cash-flows.row.dividends-paid	0	-132.9	-23	-21.5	-21	0	-65.4	0	0	0
cash-flows.row.other-financing-activites	0	-1.2	354.9	333.5	-45.6	-18.4	-7.8	12.8	23.3	35.6
cash-flows.row.net-cash-used-provided-by-financing-activities	0	281.6	78.1	322.4	-65.8	630.4	41.2	-3	-13	-6.1
cash-flows.row.effect-of-forex-changes-on-cash	0	-4.8	-1.1	3.3	-0.3	-3	2.4	-1.2	0.3	0.2
cash-flows.row.net-change-in-cash	0	258	-167.3	271.8	-189.6	393.8	19.2	35.4	12.1	8.3
cash-flows.row.cash-at-end-of-period	644.7	644.7	386.7	553.9	282.2	471.7	78	58.8	23.3	11.2
cash-flows.row.cash-at-beginning-of-period	644.7	386.7	553.9	282.2	471.7	78	58.8	23.3	11.2	2.9
cash-flows.row.operating-cash-flow	0	191.9	148.4	104	140.6	40.9	65.5	53.5	50.5	42.6
cash-flows.row.capital-expenditure	0	-91.2	-129.2	-337.4	-171.9	-31.7	-65.6	-11.3	-3.1	-8
cash-flows.row.free-cash-flow	0	100.6	19.2	-233.4	-31.4	9.2	-0.1	42.2	47.4	34.6

利润表行

C-MER Eye Care Holdings Limited 的收入与上期相比变化了 NaN%。据报告, 3309.HK 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014
income-statement-row.row.total-revenue	1924	1731.9	1112.6	699.5	576.2	429.4	311.2	248.7	198.9	156.5
income-statement-row.row.cost-of-revenue	1381.5	1366.6	803.1	535.9	392.7	280	175.8	153.7	119.2	97.4
income-statement-row.row.gross-profit	542.5	365.3	309.4	163.6	183.6	149.3	135.4	95	79.7	59
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	5	0.6	0.3	0.6	1.7	0.5	0.9	-0.1	0	0
income-statement-row.row.operating-expenses	426	389.8	311.8	177.4	135.7	101.4	77.3	37.7	30.8	30.4
income-statement-row.row.cost-and-expenses	1807.5	1756.3	1114.9	713.3	528.3	381.4	253.1	191.3	150	127.9
income-statement-row.row.interest-income	19.9	7.1	4.5	5.1	13.5	13.2	0.3	0.7	0.2	0
income-statement-row.row.interest-expense	18.1	19.7	13	10.4	7.5	0.2	0.6	0.9	1.2	1
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	4.7	-24.6	18.6	16.5	5.5	2.3	-23.6	-0.9	-1.2	-1
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	5	0.6	0.3	0.6	1.7	0.5	0.9	-0.1	0	0
income-statement-row.row.total-operating-expenses	4.7	-24.6	18.6	16.5	5.5	2.3	-23.6	-0.9	-1.2	-1
income-statement-row.row.interest-expense	18.1	19.7	13	10.4	7.5	0.2	0.6	0.9	1.2	1
income-statement-row.row.depreciation-and-amortization	220.7	223.7	148.6	113.6	78.5	25.5	8.6	12.4	11.6	11
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	116.4	-24.4	-2.3	-13.7	47.9	58.8	82.1	59.5	49.6	28.9
income-statement-row.row.income-before-tax	121.1	-49	16.2	2.8	53.4	61.2	58.5	58.6	48.4	28
income-statement-row.row.income-tax-expense	37.9	35	10.6	10.9	14.1	18.6	18.4	11.7	10.1	5.6
income-statement-row.row.net-income	62	-21.9	21.9	-6.2	41.4	42.6	40.1	46.9	38.4	22.4